Detailansicht

Wissensnetz

Person

Henrik Zetterberg

Chemiker

Name	Henrik Zetterberg
Zeit	2004- (Wirkungsdaten)
Ort	Schweden
Geschlecht	männlich
Akademischer Grad bzw. Titel	Prof. Dr.
Beruf	Chemiker (charakteristischer Beruf) Hochschullehrer
Beziehung	Göteborgs universitet Sahlgrenska Sjukhuset (Göteborg) Neurochemie (Thema) Psychiatrie (Thema)
Datensatztyp	Person
GND-Nummer	1261169018
Datensatz-ID	1261169018
Beteiligt an alle anzeigen Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease Melatonin: A potential nighttime guardian against Alzheimer’s Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts Tau protein profiling in tauopathies: a human brain study Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease Author Correction: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest Functional connectivity changes in neurodegenerative biomarker-positive athletes with repeated concussions Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer Updating the study protocol: Insight 46 – a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development – phases 2 and 3 Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case–control study of patients with bipolar disorder and healthy control individuals Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease The Taxonomy of Subjective Cognitive Decline: Proposal and First Clinical Evidence from the Geneva Memory Clinic Cohort Neuro-Specific and Immuno-Inflammatory Biomarkers in Umbilical Cord Blood in Neonatal Hypoxic-Ischemic Encephalopathy IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study 14-3-3 $$\upzeta /\updelta$$ ζ Neurofilament light as a predictor of long- and short-term outcomes in critically ill children Plasma GFAP and its association with disease severity in Huntington’s disease

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Henrik Zetterberg

Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy

Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study

An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein

Serum neurofilament light at diagnosis: a prognostic indicator for accelerated disease progression in Parkinson’s Disease

Melatonin: A potential nighttime guardian against Alzheimer’s

Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression

Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts

Tau protein profiling in tauopathies: a human brain study

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies

Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer’s disease with APPdup and Down syndrome

Circulating levels of neurofilament light chain as a biomarker of infarct and white matter hyperintensity volumes after ischemic stroke

Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

Differences in metalloproteinases and their tissue inhibitors in the cerebrospinal fluid are associated with delirium

PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease

Author Correction: Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease

Effects of time of the day at sampling on CSF and plasma levels of Alzheimer’ disease biomarkers

The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer’s disease

Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury

Variants in the MS4A cluster interact with soluble TREM2 expression on biomarkers of neuropathology

Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly

Lysosomal and synaptic dysfunction markers in longitudinal cerebrospinal fluid of de novo Parkinson’s disease

The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people

Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients

Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease

Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics

Plasma glial fibrillary acidic protein and tau: predictors of neurological outcome after cardiac arrest

Functional connectivity changes in neurodegenerative biomarker-positive athletes with repeated concussions

Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease

Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease

A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology

Correction to: Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus

Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls

A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy

Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease

Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer

Updating the study protocol: Insight 46 – a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development – phases 2 and 3

Monitoring synaptic pathology in Alzheimer’s disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives

Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case–control study of patients with bipolar disorder and healthy control individuals

Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort

Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology

CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease

Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer’s disease

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease

The Taxonomy of Subjective Cognitive Decline: Proposal and First Clinical Evidence from the Geneva Memory Clinic Cohort

Neuro-Specific and Immuno-Inflammatory Biomarkers in Umbilical Cord Blood in Neonatal Hypoxic-Ischemic Encephalopathy

IgG and kappa free light chain CSF/serum indices: evaluating intrathecal immunoglobulin production in HIV infection in comparison with multiple sclerosis

Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics

Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury

NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study

Optimal blood tau species for the detection of Alzheimer’s disease neuropathology: an immunoprecipitation mass spectrometry and autopsy study

14-3-3 $$\upzeta /\updelta$$ ζ

Neurofilament light as a predictor of long- and short-term outcomes in critically ill children

Plasma GFAP and its association with disease severity in Huntington’s disease